Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8227530 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 7 Pages |
Abstract
Despite a significant locoregional control benefit with combined radiotherapy, no survival improvement was recorded, but increased late toxicity was noted in the intestine, bladder, and vagina. Combined RT should probably be reserved for high-risk cases with two or more high-risk factors. VBT alone should be the adjuvant treatment option for purely medium-risk cases.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Bengt M.D., Ph.D., György M.D., Ph.D., HÃ¥kan M.D., Ph.D., Karin M.D., Ph.D., Caroline M.D., Ph.D., Birgitta M.D., Ph.D.,